HanchorBio Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	312.22	-	-	3.36
Cost of Revenue	-	-	-	1.32
Gross Profit	312.22	-	-	2.05
Selling, General & Admin	129.41	162.88	38.84	52.95
Research & Development	536.53	789.24	499.21	461.42
Operating Expenses	665.94	952.12	538.05	514.37
Operating Income	-353.72	-952.12	-538.05	-512.32
Interest Expense	-4.47	-4.9	-2.77	-2.5
Interest & Investment Income	7.1	6.28	7.91	1.29
Currency Exchange Gain (Loss)	-9.3	-5.36	3.12	-15.62
Other Non Operating Income (Expenses)	-103.94	-399.12	-65.44	81.72
EBT Excluding Unusual Items	-464.34	-1,355	-595.23	-447.43
Gain (Loss) on Sale of Investments	0	1.12	0.94	1.13
Other Unusual Items	-	-	2.92	-
Pretax Income	-464.33	-1,354	-591.37	-446.3
Earnings From Continuing Operations	-497.62	-1,354	-591.37	-446.3
Minority Interest in Earnings	-	-	0.02	-0.02
Net Income	-497.62	-1,354	-591.36	-446.32
Net Income to Common	-497.62	-1,354	-591.36	-446.32
Shares Outstanding (Basic)	112	67	52	44
Shares Outstanding (Diluted)	112	67	52	44
Shares Change (YoY)	115.73%	27.71%	17.68%	-
EPS (Basic)	-4.43	-20.36	-11.36	-10.09
EPS (Diluted)	-4.43	-20.36	-11.36	-10.09
Free Cash Flow	-308.09	-625.57	-461.63	-408.39
Free Cash Flow Per Share	-2.74	-9.41	-8.87	-9.23
Gross Margin	100.00%	-	-	60.87%
Operating Margin	-113.29%	-	-	-15234.11%
Profit Margin	-159.38%	-	-	-13271.57%
Free Cash Flow Margin	-98.68%	-	-	-12143.74%
EBITDA	-328.27	-927.86	-515.61	-495.85
D&A For EBITDA	25.45	24.26	22.45	16.48
EBIT	-353.72	-952.12	-538.05	-512.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.